caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet

RxCUI
1293504
RxNorm name
caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet
Display name
Caffeine/Ergotamine (Oral Pill)
Full name
caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet
Term type
SCD
Status
Active
Strength
100-1 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-29 06:02:03

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062012
Active start
062012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
caffeine100 MG / 1 EACHcaffeinecaffeine
ergotamine tartrate1 MG / 1 EACHergotamineergotamine tartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
ergotamine4025

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcaffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet1NAMES
RxNorm Namecaffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID41f88ae7-c124-5b9c-e054-00144ff88e881CODES
RxCUI12935041CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
24470-917-1024470-917ergotamine tartrate and caffeine ergotamine tartrate and caffeineCintex Services, LLCANDA040590
24470-917-4024470-917ergotamine tartrate and caffeine ergotamine tartrate and caffeineCintex Services, LLCANDA040590

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA04059024470-917ergotamine tartrate and caffeine ergotamine tartrate and caffeineANDACintex Services, LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 56 matching rows.

NDC11, Source, Active table
NDC11SourceActive
24470091710rxnav_ndcsyes
24470091740rxnav_ndcsyes
52187055510rxnav_ndcsyes
60258007001rxnav_ndcsyes
00052054220rxnav_historical_indirect
00052054291rxnav_historical_indirect
00078003400rxnav_historical_indirect
00078003428rxnav_historical_indirect
00078003434rxnav_historical_indirect
00078003442rxnav_historical_indirect
00078034905rxnav_historical_indirect
00106119510rxnav_historical_indirect
00117120002rxnav_historical_indirect
00117120003rxnav_historical_indirect
00117120005rxnav_historical_indirect
00143212001rxnav_historical
00143212005rxnav_historical
00143212030rxnav_historical
00179006770rxnav_historical
00179161770rxnav_historical
00179161771rxnav_historical
00179161772rxnav_historical
00181060850rxnav_historical_indirect
00247026810rxnav_historical
00247026812rxnav_historical
00247026820rxnav_historical
00349206501rxnav_historical_indirect
00349206510rxnav_historical_indirect
00527121701rxnav_historical_indirect
00527121710rxnav_historical_indirect
00536378601rxnav_historical_indirect
00771063201rxnav_historical_indirect
00771063202rxnav_historical_indirect
00771063204rxnav_historical_indirect
00771112501rxnav_historical_indirect
00771112504rxnav_historical_indirect
00779037425rxnav_historical_indirect
00781199501rxnav_historical_indirect
00781540501rxnav_historical_indirect
00781599501rxnav_historical_indirect
00814138214rxnav_historical_indirect
00839609206rxnav_historical_indirect
00904265260rxnav_historical_indirect
00904265270rxnav_historical_indirect
11845081001rxnav_historical_indirect
46672019801rxnav_historical
46672019810rxnav_historical
49648080301rxnav_historical_indirect
53261003412rxnav_historical_indirect
53261003420rxnav_historical_indirect
54868153900rxnav_historical
55289096012rxnav_historical_indirect
60168059001rxnav_historical_indirect
63874107203rxnav_historical_indirect
67263049901rxnav_historical_indirect
68071031505rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CafergotERGOTAMINE TARTRATE AND CAFFEINETrifluent Pharma, LLC4db7eece-2eef-bc1b-e063-6394a90a98cb2026-03-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1293504
ergotamine tartrate and caffeineERGOTAMINE TARTRATE AND CAFFEINECintex Services, LLC41f88ae7-c124-5b9c-e054-00144ff88e882025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 24470-917-10
ndc (package): 24470-917-40
ndc (product): 24470-917
ndc11 (package): 24470091710
ndc11 (package): 24470091740
rxcui: 1293504

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
41f88ae7-c124-5b9c-e054-00144ff88e88ergotamine tartrate 1 MG / caffeine 100 MG Oral Tablet [PSN] · caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet [SCD]25Ergotamine Tartrate and Caffeine Tablets, USP 1 mg/100 mg20250327
19479eeb-f507-48a8-bca3-c9cc0a0f6021ergotamine tartrate 1 MG / caffeine 100 MG Oral Tablet [PSN] · caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet [SCD]22Ergotamine Tartrate and Caffeine20130410
4db7eece-2eef-bc1b-e063-6394a90a98cbergotamine tartrate 1 MG / caffeine 100 MG Oral Tablet [PSN] · caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet [SCD]21Ergotamine Tartrate and Caffeine Tablets, USP 1 mg/100 mg20260323

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
41f88ae7-c124-5b9c-e054-00144ff88e88Ergotamine Tartrate and Caffeine Tablets, USP 1 mg/100 mgCintex Services, LLC20250327
d7acf745-e17e-009d-e053-2a95a90ab32eErgotamine Tartrate and Caffeine Tablets, USP 1 mg / 100 mgKMM Pharmaceuticals, LLC20220210
6a105e44-b558-45c1-9c91-fe1f3dfc5bd5Ergotamine Tartrate and Caffeine Tablets, USP 1 mg/100 mgMikart, LLC20200609
b4a06de6-f837-43a8-ae7a-aadb38dd2a7dCafergot® (ergotamine tartrate and caffeine tablets, USP)Sandoz Inc20191216
19479eeb-f507-48a8-bca3-c9cc0a0f6021Ergotamine Tartrate and CaffeineWest-Ward Pharmaceutical Corp20130410
d286b6ae-299a-4c45-84a1-088d65fe9b6cNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02CAErgot alkaloidsATC1-4ergotamine
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD001393AzolesCHEMci_chemclassergotamine tartrate
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD002219CarbamatesCHEMci_chemclassergotamine tartrate
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine tartrate
MEDRTD005663FuransCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD019888NelfinavirCHEMci_chemclassergotamine tartrate
MEDRTD019438RitonavirCHEMci_chemclassergotamine tartrate
MEDRTD013449SulfonamidesCHEMci_chemclassergotamine tartrate
MEDRTD000033Abortion, ThreatenedDISEASEci_withergotamine tartrate
MEDRTD000788Angina Pectoris, VariantDISEASEmay_diagnoseergotamine tartrate
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine tartrate
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine tartrate
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD006973HypertensionDISEASEci_withergotamine tartrate
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine tartrate
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD008107Liver DiseasesDISEASEci_withergotamine tartrate
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine tartrate
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine tartrate
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD006473Postpartum HemorrhageDISEASEmay_preventergotamine tartrate
MEDRTD006473Postpartum HemorrhageDISEASEmay_treatergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD018805SepsisDISEASEci_withergotamine tartrate
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine tartrate
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine tartrate
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine tartrate
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008376Cutaneous Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH100 MG / 1 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA040590
CODESSNOMEDCT322793003
CODESVUID4005091
NAMESPrescribable Synonymergotamine tartrate 1 MG / caffeine 100 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File